Bambu Lab H3C launches today. Nine independent PrintTools™ that allow multiple nozzle sizes in a single print. Powered by SwapTek™, Print-to-print tool switch only takes 6 seconds. Multiple toolheads with multiple possibilities. Print, cut, draw and deboss. All on the same machine. We built this machine. Now we want to see what you make with it. -------------------------- To celebrate the launch, we're sending one H3C Combo to a maker ready for it. How to enter: • Follow @BambulabGlobal • Like + Repost with: "Bambu Lab H3C. Tool Changer. Game Changer!" • Comment: Which H3C feature impressed you the most? Winner revealed: Nov 6, 4AM EST Explore the H3C:

BAMBUSA THERAPEUTICS OPENS BELOW ITS $16 IPO PRICE IN ITS NASDAQ DEBUT $BBTX first traded at $15.18, about 5% under the offer price, after the biotech's upsized $169 million IPO priced at the midpoint of its range, per Nasdaq data and the company.

Bambusa, an early-stage biotech focused on dermatology and autoimmune diseases, has raised $168.9 million in an upsized US initial public offering that priced at the midpoint of its marketed range

BAMBUSA THERAPEUTICS PRICES UPSIZED $169 MILLION IPO AT $16, THE MIDPOINT OF ITS RANGE The Boston biotech, built on antibody assets it bought from a BioNTech unit, sold 10.56 million shares, up from 9.38 million planned. $BBTX starts trading on Nasdaq on Friday, per the company.

Bambo watched Jin diagram the plan with a stylus on the table surface. When Jin finished, Bambo asked one question. Jin answered it. Bambo said nothing else, which meant the plan was going forward. They quietly smiled. Plan was done. @FinalbosuX